Literature DB >> 31418914

Methylphenidate and stuttering.

Thierry Trenque1,2, Gwladys Claustre1, Emmanuelle Herlem1, Zoubir Djerada1, Agathe Trenque1, Aurore Morel1, Brahim Azzouz1,2.   

Abstract

Entities:  

Keywords:  Vigibase; methylphenidate; stuttering

Mesh：

Substances：

Year:  2019        PMID： 31418914      PMCID： PMC6848957          DOI： 10.1111/bcp.14097

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  22 in total

1.  Developmental stuttering and Parkinson's disease: the effects of levodopa treatment.

Authors:  J M Anderson; J D Hughes; L J Rothi; G P Crucian; K M Heilman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

2.  Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.

Authors:  Nora D Volkow; Gene-Jack Wang; Dardo Tomasi; Scott H Kollins; Tim L Wigal; Jeffrey H Newcorn; Frank W Telang; Joanna S Fowler; Jean Logan; Christopher T Wong; James M Swanson
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

Review 3.  The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.

Authors:  Stephen V Faraone
Journal:  Neurosci Biobehav Rev       Date:  2018-02-08       Impact factor: 8.989

Review 4.  Stuttering: Clinical and research update.

Authors:  Hector R Perez; James H Stoeckle
Journal:  Can Fam Physician       Date:  2016-06       Impact factor: 3.275

Review 5.  A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD).

Authors:  Alok Sharma; Justin Couture
Journal:  Ann Pharmacother       Date:  2013-11-01       Impact factor: 3.154

Review 6.  Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.

Authors:  Nora D Volkow; James M Swanson
Journal:  Am J Psychiatry       Date:  2003-11       Impact factor: 18.112

7.  Influence of Methylphenidate on the Frequency of Stuttering: A Randomized Controlled Trial.

Authors:  Henk Rabaeys; Henny-Annie Bijleveld; Dirk Devroey
Journal:  Ann Pharmacother       Date:  2015-07-30       Impact factor: 3.154

8.  Shifted dynamic interactions between subcortical nuclei and inferior frontal gyri during response preparation in persistent developmental stuttering.

Authors:  F Luise Metzger; Tibor Auer; Gunther Helms; Walter Paulus; Jens Frahm; Martin Sommer; Nicole E Neef
Journal:  Brain Struct Funct       Date:  2017-07-24       Impact factor: 3.270

9.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

Review 10.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.